Nektar Therapeutics (NKTR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NKTR.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
NKTR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Nektar Therapeutics's percent of analysts bearish on the stock is lower than nearly 100% of all US stocks.
- The variance in analysts' estimates of NKTR is less than 0.450000000000003% of all US stocks.
- NKTR has a higher upside potential (average analyst target price relative to current price) than 95.27% of stocks in the large market cap category.
- The number of analysts covering the stock of NKTR is greater than 90.56% of Pharmaceutical Products stocks.
- Nektar Therapeutics's percentage of analysts bullish on the stock is greater than 25.6% of Pharmaceutical Products stocks.
- The average analyst price target of NKTR is higher than 27.48% of stocks in the large market cap category.
- Nektar Therapeutics's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.
What is the outlook for NKTR? Use POWR Ratings for clearer insight into price direction.